Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001326732-24-000055
Filing Date
2024-10-21
Accepted
2024-10-21 16:18:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G zenasbiopharmainc-xencorsc.htm SC 13G 45313
  Complete submission text file 0001326732-24-000055.txt   47053
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filed by) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451
Business Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Subject) CIK: 0001953926 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94625 | Film No.: 241383696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)